Clinical Trial Update: Glucocorticosteroid Therapy on Drug-induced Liver Injury: a Prospective Non-randomized Concurrent Control Trial [Phase 4]

View source ↗

Summary

A Phase 4 prospective non-randomized concurrent control trial evaluating glucocorticosteroid therapy for drug-induced liver injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-induced Liver Injury

Drugs mentioned

• glucocorticosteroid therapy

Snippet

Sponsor: Li Yang | Conditions: Drug-induced Liver Injury | Phase 4 | Status: UNKNOWN